We urge you to utilize Ellomay Capital fundamental analysis to see if markets are presently mispricing the company. In plain English you can exercise it to find out if Ellomay Capital is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. . We found thirty available fundamental indicators for Ellomay Capital Ltd which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Ellomay Capital fundamentals including its Price to Sales, Gross Profit and the relationship between Price to Book and Revenue . Use Ellomay Capital to enhance returns of your portfolios. The stock experiences normal upward fluctuation. Check odds of Ellomay Capital to be traded at S3287.55 in 30 days.
Ellomay Capital Company Summary
Ellomay Capital competes with Bezeq Israel, Israel Chemicals, NICE Ltd, Perrigo Company, and Elbit Systems. Ellomay Capital Ltd., together with its subsidiaries, produces and sells renewable and clean energy in Israel, Italy, Spain, and the Netherlands. Ellomay Capital Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel. Ellomay Capital is traded on Tel Aviv Stock Exchange in Israel.
Ellomay Capital Current Valuation vs Working Capital
Ellomay Capital Ltd is rated below average in current valuation category among related companies. It is rated # 5 in working capital category among related companies reporting about 0.05 of Working Capital per Current Valuation. The ratio of Current Valuation to Working Capital for Ellomay Capital Ltd is roughly 19.02
Ellomay Capital Market Fundamentals
Ellomay Capital Financial Distress Probability
Chance of Financial Distress
Ellomay Capital Ltd has less than 43 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info
Additionally see Investing Opportunities. Please also try Instant Ratings module to determine any equity ratings based on digital recommendations. macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.